{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:04:58Z","timestamp":1759334698556,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.arcmed.2009.04.002","type":"journal-article","created":{"date-parts":[[2009,7,15]],"date-time":"2009-07-15T04:47:24Z","timestamp":1247633244000},"page":"285-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Downregulation of T Helper Cell Type 3 in Patients with Acute Coronary Syndrome"],"prefix":"10.1016","volume":"40","author":[{"given":"Qing-wei","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-song","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-bo","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-dong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song-nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-shan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-yin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-tang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2009.04.002_bib1","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000087480.94275.97","article-title":"From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: I","volume":"108","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.arcmed.2009.04.002_bib2","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1161\/01.ATV.0000142373.72662.20","article-title":"Finding vulnerable atherosclerotic plaques: is it worth the effort?","volume":"24","author":"Madjid","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.pathol.1.110304.100100","article-title":"Inflammation and atherosclerosis","volume":"1","author":"Hansson","year":"2006","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib4","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1161\/01.ATV.0000245830.29764.84","article-title":"T cells in atherogenesis: for better or for worse?","volume":"26","author":"Robertson","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","article-title":"Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines","volume":"145","author":"Frosteg\u00e5rd","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arcmed.2009.04.002_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.RES.0000029784.15893.10","article-title":"Innate and adaptive immunity in the pathogenesis of atherosclerosis","volume":"91","author":"Hansson","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.arcmed.2009.04.002_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/01.HYP.0000140270.26523.9b","article-title":"Hypertension: a novel regulator of adaptive immunity in atherosclerosis?","volume":"44","author":"Tedgui","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.arcmed.2009.04.002_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/01.HYP.0000140269.55873.7b","article-title":"Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-\/- mice","volume":"44","author":"Mazzolai","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.arcmed.2009.04.002_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejim.2003.09.002","article-title":"The role of T-lymphocyte subpopulations in acute myocardial infarction","volume":"14","author":"Blum","year":"2003","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.arcmed.2009.04.002_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.ATV.20.1.10","article-title":"Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice","volume":"20","author":"Paulsson","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib11","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.jacc.2005.03.040","article-title":"Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes","volume":"45","author":"Methe","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib12","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1161\/01.CIR.101.25.2883","article-title":"Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes","volume":"101","author":"Liuzzo","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.arcmed.2009.04.002_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.jid.5700004","article-title":"Regulatory T cells","volume":"26","author":"Beissert","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib14","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1161\/ATVBAHA.107.153064","article-title":"The influence of the regulatory T lymphocytes on atherosclerosis","volume":"27","author":"Gotsman","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000092576","article-title":"Type I regulatory T cells in autoimmunity and inflammatory diseases","volume":"140","author":"Veldman","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.immuni.2008.07.001","article-title":"Regulatory T cells and inflammation: better late than never","volume":"29","author":"Ziegler","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.arcmed.2009.04.002_bib17","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7520605","article-title":"Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis","volume":"265","author":"Chen","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2009.04.002_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1172\/JCI118779","article-title":"Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor \u03b21-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients","volume":"98","author":"Fukaura","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcmed.2009.04.002_bib19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.0105-2896.2005.00280.x","article-title":"Oral tolerance","volume":"206","author":"Faria","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.arcmed.2009.04.002_bib20","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.CIR.0000089083.61317.A1","article-title":"Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice","volume":"108","author":"Mallat","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.arcmed.2009.04.002_bib21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/39614","article-title":"A CD4+ T-cell subset inhibits antigen-specific T cell responses and prevents colitis","volume":"389","author":"Groux","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2009.04.002_bib22","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.4049\/jimmunol.166.9.5530","article-title":"IFN-\u03b1 and IL-10 induce the differentiation of human type 1 T regulatory cells","volume":"166","author":"Levings","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.arcmed.2009.04.002_bib24","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.106.633263","article-title":"Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule","volume":"114","author":"Gotsman","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.arcmed.2009.04.002_bib25","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.ATV.0000259365.31469.89","article-title":"Role of naturally occurring CD4 + CD25+ regulatory T cells in experimental atherosclerosis","volume":"27","author":"Mor","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1034\/j.1600-065X.2001.1820117.x","article-title":"Induction and mechanism of action of transforming growth factor-\u03b2-secreting Th3 regulatory cells","volume":"182","author":"Weiner","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1016\/j.arcmed.2009.04.002_bib27","first-page":"143","article-title":"Oral tolerance: therapeutic implications for autoimmune diseases","volume":"13","author":"Faria","year":"2006","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib28","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1172\/JCI1216","article-title":"Hypercholesterolemia is associated with a Th1\/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice","volume":"101","author":"Zhou","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcmed.2009.04.002_bib29","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9440(10)63471-2","article-title":"The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"163","author":"Davenport","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib30","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1161\/hq0302.104905","article-title":"Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-\/- mice","volume":"22","author":"King","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.jid.5700004","article-title":"Regulatory T cells","volume":"126","author":"Beissert","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0167-5699(97)01053-0","article-title":"Oral tolerance: immune mechanisms and treatment of autoimmune diseases","volume":"18","author":"Weiner","year":"1997","journal-title":"Immunol Today"},{"key":"10.1016\/j.arcmed.2009.04.002_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4049\/jimmunol.178.1.179","article-title":"Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice","volume":"178","author":"Carrier","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.178.1.172","article-title":"Th3 cells in peripheral tolerance. II. TGF-beta-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity","volume":"178","author":"Carrier","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib35","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+ CD25\u2212 naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.arcmed.2009.04.002_bib36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","article-title":"Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses","volume":"22","author":"Sakaguchi","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib37","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.ATV.0000114567.76772.33","article-title":"Transforming growth factor \u03b2 and atherosclerosis: so far, so good for the protective cytokine hypothesis","volume":"24","author":"Grainger","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib38","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/01.ATV.0000225287.20034.2c","article-title":"Transforming growth factor-\u03b2s and vascular disorders","volume":"26","author":"Bobik","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib39","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1161\/hh2201.099415","article-title":"Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice","volume":"89","author":"Mallat","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.arcmed.2009.04.002_bib40","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/01.ATV.0000019729.39500.2F","article-title":"Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression","volume":"22","author":"Lutgens","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib41","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bbrc.2006.04.010","article-title":"Suppression of atherogenesis by delivery of TGF\u03b21 ACT using adeno-associated virus type 2 in LDLR knockout mice","volume":"344","author":"Li","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.arcmed.2009.04.002_bib42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/376177a0","article-title":"Peripheral deletion of antigen-reactive T cells in oral tolerance","volume":"376","author":"Chen","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2009.04.002_bib43","doi-asserted-by":"crossref","first-page":"6688","DOI":"10.1073\/pnas.91.14.6688","article-title":"Induction of anergy or active suppression following oral tolerance is determined by antigen dosage","volume":"91","author":"Friedman","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2009.04.002_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/cimm.1996.1049","article-title":"Clonal anergy is a potent mechanism of oral tolerance in the suppression of acute antigen-induced arthritis in rats by oral administration of the inducing antigen","volume":"175","author":"Inada","year":"1997","journal-title":"Cell Immunol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib45","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0735-1097(02)02135-6","article-title":"Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis induced and high-fat-diet-driven atherosclerotic lesions","volume":"40","author":"Harats","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.arcmed.2009.04.002_bib46","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cardiores.2004.01.028","article-title":"Suppression of early atherosclerosis in LDL receptor deficient mice by oral tolerance with beta 2-glycoprotein I","volume":"62","author":"George","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.arcmed.2009.04.002_bib47","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1161\/CIRCULATIONAHA.106.615609","article-title":"Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis","volume":"114","author":"van Puijvelde","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.arcmed.2009.04.002_bib48","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2796.2008.01944.x","article-title":"Regulatory T-cell immunity and its relevance to atherosclerosis","volume":"263","author":"Taleb","year":"2008","journal-title":"J Intern Med"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440909000496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440909000496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:36:58Z","timestamp":1759261018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440909000496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0188440909000496"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2009.04.002","relation":{},"ISSN":["0188-4409"],"issn-type":[{"type":"print","value":"0188-4409"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Downregulation of T Helper Cell Type 3 in Patients with Acute Coronary Syndrome","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2009.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}